Traduction de «Clinical biochemistry » (Anglais → Néerlandais) :

TERMINOLOGIE

clinical biochemistry test
klinisch-biochemische test

Clinical biochemistry department
afdeling chemische pathologie

clinical chemistry | medical biochemistry | clinical biochemistry | clinical bio-chemistry
klinische biochemie

chemical pathology | clinical biochemistry | clinical chemistry
klinische chemie

biochemistry laboratory technician | biochemistry technologist | biochemistry technician | biology technician
laboratoriumingenieur biochemie | routineanalist biochemie | biochemisch laborant | technicus-biochemicus in een controlelaboratorium in de industrie

biochemistry laboratory technician | biochemistry technologist | bacteriology technician | bacteriology technician
bacteriologisch analist wateronderzoek | laboratoriumingenieur bacteriologie | bacteriologisch laborant | bacterioloog

biochemistry | Schueszler biochemistry
biochemie

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptoms, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...
Omschrijving: Dit blok omvat een grote verscheidenheid van stoornissen van verschillende ernst en klinische vorm, die evenwel alle aan het gebruik van een of meer psychoactieve middelen, al dan niet op medisch voorschrift, zijn toe te schrijven. De betrokken stof wordt aangegeven door middel van het derde teken van de code en het vierde teken specificeert de klinische toestand; deze codering dient, waar nodig, gebruikt te worden voor elk gespecificeerd middel, met dien verstande dat niet elk vierde teken van toepassing is op elke stof.

The association of four anomalies: intellectual deficit, microcephaly, palate anomalies and ocular abnormalities. It has been described in five patients (three boys and two girls). The clinical manifestations are evident from birth. The palate anomal
oculo-palato-cerebraal syndroom

An intermediate form of lichen myxedematosus (a form of mucin dermal deposit) which does not meet the criteria for either scleromyxedema or the localized form. Three clinical subtypes have been described and include scleromyxedema without monoclonal
atypische lichen myxoedematosus

TRADUCTIONS EN CONTEXTE

Fasted blood samples from a defined site are taken from 10 randomly selected cohort 1A males and females per dose group at termination, stored under appropriate conditions and subjected to standard clinical biochemistry, including the assessment of serum levels for thyroid hormones (T4 and TSH), haematology (total and differential leukocyte plus erythrocyte counts) and urinalysis assessments.
Aan het einde worden van 10 willekeurig geselecteerde nuchtere mannetjes en vrouwtjes in cohort 1A per dosisgroep bloedmonsters genomen van een gedefinieerde plaats, die onder de juiste omstandigheden worden bewaard en worden onderworpen aan standaard klinisch-biochemische bepalingen, waaronder de beoordeling van serumspiegels van schildklierhormonen (T4 en TSH), hematologie (totaal aantal en gedifferentieerde aantallen witte bloedcellen plus aantal rode bloedcellen) en urineonderzoek.

Pups not assigned to cohorts will be submitted to clinical biochemistry (paragraph 55) and gross necropsy (paragraph 68).
Jongen die niet aan cohorten zijn toegewezen, worden onderworpen aan klinisch biochemisch onderzoek (punt 55) en macroscopische obductie (punt 68).

Fasted blood samples from a defined site are taken from 10 randomly-selected P males and females per dose group at termination, stored under appropriate conditions and subjected to partial or full-scale haematology, clinical biochemistry, assay of T4 and TSH or other examinations suggested by the known effect profile of the test chemical (see OECD Guidance Document 151(40)).
Aan het einde worden van 10 willekeurig geselecteerde nuchtere P-mannetjes en -vrouwtjes per dosisgroep bloedmonsters genomen van een gedefinieerde plaats, die onder de juiste omstandigheden worden bewaard en worden onderworpen aan gedeeltelijke of volledige hematologische en klinisch-biochemische bepalingen, T4- en TSH-test of andere onderzoeken die aangewezen zijn op basis van het bekende effectprofiel van de teststof (zie OESO-leidraad nr. 151 (40)).